Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

The influence of single nucleotide polymorphisms on the association between dietary acrylamide intake and endometrial cancer risk.

Hogervorst JG, van den Brandt PA, Godschalk RW, van Schooten FJ, Schouten LJ.

Sci Rep. 2016 Oct 7;6:34902. doi: 10.1038/srep34902.

2.

Interactions between dietary acrylamide intake and genes for ovarian cancer risk.

Hogervorst JGF, van den Brandt PA, Godschalk RWL, van Schooten FJ, Schouten LJ.

Eur J Epidemiol. 2017 May;32(5):431-441. doi: 10.1007/s10654-017-0244-0. Epub 2017 Apr 8.

3.

Interaction between dietary acrylamide intake and genetic variants for estrogen receptor-positive breast cancer risk.

Hogervorst JGF, van den Brandt PA, Godschalk RWL, van Schooten FJ, Schouten LJ.

Eur J Nutr. 2019 Apr;58(3):1033-1045. doi: 10.1007/s00394-018-1619-z. Epub 2018 Feb 14.

4.

Lung cancer risk in relation to dietary acrylamide intake.

Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, van den Brandt PA.

J Natl Cancer Inst. 2009 May 6;101(9):651-62. doi: 10.1093/jnci/djp077. Epub 2009 Apr 28.

PMID:
19401552
5.

The Role of Genetic Variants in the Association between Dietary Acrylamide and Advanced Prostate Cancer in the Netherlands Cohort Study on Diet and Cancer.

Perloy A, Schouten LJ, van den Brandt PA, Godschalk R, van Schooten FJ, Hogervorst JGF.

Nutr Cancer. 2018 May-Jun;70(4):620-631. doi: 10.1080/01635581.2018.1460682. Epub 2018 Apr 26.

PMID:
29697282
6.

A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer.

Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, van den Brandt PA.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2304-13.

7.

Dietary acrylamide intake and the risk of endometrial or ovarian cancers in Japanese women.

Kotemori A, Ishihara J, Zha L, Liu R, Sawada N, Iwasaki M, Sobue T, Tsugane S; JPHC Study Group.

Cancer Sci. 2018 Oct;109(10):3316-3325. doi: 10.1111/cas.13757. Epub 2018 Aug 24.

8.

Dietary acrylamide intake and the risk of renal cell, bladder, and prostate cancer.

Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, van den Brandt PA.

Am J Clin Nutr. 2008 May;87(5):1428-38.

PMID:
18469268
9.

Dietary acrylamide intake and brain cancer risk.

Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, van den Brandt PA.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1663-6. doi: 10.1158/1055-9965.EPI-08-1133. Epub 2009 Apr 21.

10.

Dietary acrylamide intake is not associated with gastrointestinal cancer risk.

Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, van den Brandt PA.

J Nutr. 2008 Nov;138(11):2229-36. doi: 10.3945/jn.108.092957.

PMID:
18936224
11.

In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans.

Doroshyenko O, Fuhr U, Kunz D, Frank D, Kinzig M, Jetter A, Reith Y, Lazar A, Taubert D, Kirchheiner J, Baum M, Eisenbrand G, Berger FI, Bertow D, Berkessel A, Sörgel F, Schömig E, Tomalik-Scharte D.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):433-43. doi: 10.1158/1055-9965.EPI-08-0832. Epub 2009 Feb 3.

12.

Dietary acrylamide intake and risk of endometrial cancer in prospective cohort studies.

Je Y.

Arch Gynecol Obstet. 2015 Jun;291(6):1395-401. doi: 10.1007/s00404-014-3595-8. Epub 2014 Dec 17.

PMID:
25516180
13.

A prospective study on dietary acrylamide intake and the risk for breast, endometrial, and ovarian cancers.

Wilson KM, Mucci LA, Rosner BA, Willett WC.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2503-15. doi: 10.1158/1055-9965.EPI-10-0391. Epub 2010 Aug 6.

14.

Biomarkers of human exposure to acrylamide and relation to polymorphisms in metabolizing genes.

Duale N, Bjellaas T, Alexander J, Becher G, Haugen M, Paulsen JE, Frandsen H, Olesen PT, Brunborg G.

Toxicol Sci. 2009 Mar;108(1):90-9. doi: 10.1093/toxsci/kfn269. Epub 2009 Jan 8.

15.

Long-term dietary acrylamide intake and risk of endometrial cancer in a prospective cohort of Swedish women.

Larsson SC, Håkansson N, Akesson A, Wolk A.

Int J Cancer. 2009 Mar 1;124(5):1196-9. doi: 10.1002/ijc.24002.

16.

The polymorphism rs2480258 within CYP2E1 is associated with different rates of acrylamide metabolism in vivo in humans.

Pellè L, Carlsson H, Cipollini M, Bonotti A, Foddis R, Cristaudo A, Romei C, Elisei R, Gemignani F, Törnqvist M, Landi S.

Arch Toxicol. 2018 Jun;92(6):2137-2140. doi: 10.1007/s00204-018-2211-2. Epub 2018 May 10.

PMID:
29748789
17.

Long-term dietary acrylamide intake and risk of epithelial ovarian cancer in a prospective cohort of Swedish women.

Larsson SC, Akesson A, Wolk A.

Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):994-7. doi: 10.1158/1055-9965.EPI-08-0868. Epub 2009 Feb 17.

18.

Dietary acrylamide and risk of prostate cancer.

Wilson KM, Giovannucci E, Stampfer MJ, Mucci LA.

Int J Cancer. 2012 Jul 15;131(2):479-87. doi: 10.1002/ijc.26383. Epub 2011 Sep 14.

19.

Dietary aflatoxin B1 intake, genetic polymorphisms of CYP1A2, CYP2E1, EPHX1, GSTM1, and GSTT1, and gastric cancer risk in Korean.

Eom SY, Yim DH, Zhang Y, Yun JK, Moon SI, Yun HY, Song YJ, Youn SJ, Hyun T, Park JS, Kim BS, Lee JY, Kim YD, Kim H.

Cancer Causes Control. 2013 Nov;24(11):1963-72. doi: 10.1007/s10552-013-0272-3. Epub 2013 Aug 15.

PMID:
23949201
20.

Prospective analysis of vitamin D and endometrial cancer risk.

Liu JJ, Bertrand KA, Karageorgi S, Giovannucci E, Hankinson SE, Rosner B, Maxwell L, Rodriguez G, De Vivo I.

Ann Oncol. 2013 Mar;24(3):687-92. doi: 10.1093/annonc/mds509. Epub 2012 Nov 7.

Supplemental Content

Support Center